Glucagon-Like Peptide-1 Receptor Agonists: all 1,407 studies that test it
Page 1 of 15. Open to participants first (306), then studies with results posted, then the rest; newest registration first within each.
- Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity.RecruitingNCT07891156Phase 2/3
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesNot yet recruitingNCT07881458Phase 3
- A Study of EloraTZP in Adult Participants With Obesity Without Type 2 DiabetesNot yet recruitingNCT07881432Phase 3
- Semaglutide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07879612Phase 2
- Short Term Effects of Semaglutide on Body Composition and PerformanceNot yet recruitingNCT07874971Not applicable
- Long-Term Effects of Semaglutide on Body Composition and Performance in RunningNot yet recruitingNCT07874932Not applicable
- PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility StudyRecruitingNCT07874828Phase 2
- FutureShape FamilyNot yet recruitingNCT07872904Phase 4
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide MedicationRecruitingNCT07868354Phase 1
- Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative StudyRecruitingNCT07866183Not applicable
- Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric SurgeryNot yet recruitingNCT07859189Phase 4
- Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric SurgeryNot yet recruitingNCT07859176Phase 4
- Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight GainNot yet recruitingNCT07859163Phase 4
- Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE)Not yet recruitingNCT07859150Phase 4
- Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or HigherNot yet recruitingNCT07859137Phase 4
- Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant AccessNot yet recruitingNCT07858331Phase 4
- SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose WeightNot yet recruitingNCT07855900Phase 3
- A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide MedicationRecruitingNCT07855133Phase 1
- ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver DiseaseNot yet recruitingNCT07850063Phase 3
- SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose WeightNot yet recruitingNCT07850050Phase 3
- Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea: A Randomised Comparative Effectiveness TrialNot yet recruitingNCT07846865Phase 2/3
- SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 YearsNot yet recruitingNCT07845994Phase 3
- A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body WeightNot yet recruitingNCT07845578Phase 1
- Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese ParticipantsNot yet recruitingNCT07840729Phase 1
- Efficacy of Tirzepatide for Weight Management in Patients With Suboptimal Weight Loss After Bariatric Surgery: A Randomized, Double-Blind, Placebo-Controlled Clinical TrialNot yet recruitingNCT07829198Phase 3
- Randomized Controlled Trial of Tirzepatide for Methamphetamine Use DisorderRecruitingNCT07825857Phase 2
- Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial CancerNot yet recruitingNCT07820358Phase 2
- Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)RecruitingNCT07817875Phase 3
- Tirzepatide and Levonorgestrel IUD Therapy for EIN and Early-Stage Endometrial CancerNot yet recruitingNCT07812636Early Phase 1
- A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or ObesityRecruitingNCT07803744Phase 1
- Postpartum Semaglutide to Reduce Cardiometabolic Risk After Gestational Diabetes MellitusNot yet recruitingNCT07797036Phase 2/3
- A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 ObesityRecruitingNCT07794579Phase 3
- A Study of Orforglipron (LY3502970) in Chinese Participants With Obesity or Overweight and Weight-Related Health ProblemsNot yet recruitingNCT07790861Phase 3
- Impact of Using a GLP1 on Treatment Related Side Effects of Lung Cancer Patients Receiving LorlatinibNot yet recruitingNCT07782359Phase 1
- OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management ProgrammeRecruitingNCT07779343Not applicable
- A Study to Investigate the Efficacy and Safety of Elecoglipron in Asian Participants With Obesity or Overweight With or Without Type 2 Diabetes MellitusRecruitingNCT07775404Phase 3
- Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use OutcomesNot yet recruitingNCT07772960Phase 1
- Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body WeightRecruitingNCT07770841Phase 3
- Semaglutide and Structured Lifestyle Support to Improve Heart and Blood Vessel Health in Postmenopausal Obese Breast Cancer Survivors Taking Aromatase InhibitorsNot yet recruitingNCT07769047Phase 4
- A Study to Compare How 2 Different Formulations of Survodutide Are Taken up in the Body When Given by Injection in Healthy Men and Women With and Without Overweight or ObesityRecruitingNCT07768813Phase 1
- A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEFRecruitingNCT07761117Phase 3
- GLP-1s in Hip and Knee ArthroplastyNot yet recruitingNCT07755085Phase 4
- A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood SugarRecruitingNCT07754461Phase 3
- A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.RecruitingNCT07753993Phase 3
- GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPDNot yet recruitingNCT07747805Phase 2
- A Study of BGM0504 in Early T2DM With ObesityRecruitingNCT07743983Phase 3
- PATHS-T2D: A Recall-by-Genotype Study of Physiologic and Pharmacologic ResponsesNot yet recruitingNCT07739537Phase 4
- Evaluation of the Efficacy and Safety of Tirzepatide, a Dual GLP-1/GIP Agonist, on Functional Capacity in Reduced Ejection Fraction Heart Failure Patients With ObesityNot yet recruitingNCT07738276Phase 3
- Tirzepatide for Treatment of CCCARecruitingNCT07734870Phase 2
- Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized TrialNot yet recruitingNCT07734792Phase 2/3
- Effects of Semaglutide on Brain Dopamine Responses to Food Cues in Adults With Obesity and Food Addiction TendenciesRecruitingNCT07732426Not applicable
- Semaglutide for Low Back PainNot yet recruitingNCT07731256Phase 2
- Switching to Oral Weight Management Pharmacotherapy to Prevent Weight Regain After GLP-1 Therapy DiscontinuationNot yet recruitingNCT07729332Phase 4
- A Proof-of-Concept Study to Evaluate Topical-Lingual Semaglutide in Adults With ObesityRecruitingNCT07728383Phase 4
- Preoperative Semaglutide Prior to Radical ProstatectomyNot yet recruitingNCT07727473Early Phase 1
- Effect of Tirzepatide on Recurrence of Atrial Fibrillation After Catheter Ablation in Obese PatientsNot yet recruitingNCT07715929Phase 4
- Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIVEnrolling by invitationNCT07707778Phase 4
- Effect of Tirzepatide on Diabetic Peripheral Sensorimotor NeuropathyNot yet recruitingNCT07706088Phase 4
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use DisorderEnrolling by invitationNCT07693608Phase 2
- Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA TrialNot yet recruitingNCT07676331Phase 2
- Tirzepatide in the Treatment of Cannabis Use DisorderNot yet recruitingNCT07671248Phase 3
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 DiabetesRecruitingNCT07668336Phase 3
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMRecruitingNCT07667803Phase 3
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background InsulinRecruitingNCT07664553Phase 3
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes MellitusRecruitingNCT07662213Phase 3
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinRecruitingNCT07662135Phase 3
- A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusRecruitingNCT07662109Phase 3
- A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes MellitusRecruitingNCT07662044Phase 3
- A Study to Evaluate Efficacy and Safety of BGM0504 Tablets in Overweight or Obese Participants Without DiabetesRecruitingNCT07658560Phase 2
- Interleukine-2 (IL-2) Plus Semaglutide in Alzheimer's DiseaseRecruitingNCT07651319Phase 1/2
- Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular DystrophyNot yet recruitingNCT07642635Phase 1/2
- Tirzepatide on Atrial Fibrillation Recurrence After Catheter Ablation in Patients With Obesity and HFpEFNot yet recruitingNCT07630454Phase 4
- GLP-1 RA Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular CancerRecruitingNCT07627191Early Phase 1
- Brown Adipose Tissue as a Mechanistic Determinant of Semaglutide Treatment Response in Obesity (BAT-Sema Study)Not yet recruitingNCT07621640Not applicable
- GLP-1 Agonists for Prevention of Recurrent Hypertriglyceridemic Acute PancreatitisNot yet recruitingNCT07617155Phase 4
- GLP-1 Receptor Agonist in Primary Intracerebral Hemorrhage: A Phase 2 Randomized TrialNot yet recruitingNCT07613437Phase 2
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan FastingRecruitingNCT07613307Phase 3
- Tirzepatide in the Treatment of Endometrial CancerNot yet recruitingNCT07605247Phase 2
- Multi-Site Trial of Tirzepatide for Smoking CessationRecruitingNCT07602699Phase 2
- Translational Health Research Into Vascular and Neurocognitive Effects of Weight LossRecruitingNCT07592546Phase 4
- Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.RecruitingNCT07588438Phase 4
- Personalized Pharmaco-Lifestyle Interventions for Severe Mental Illnesses (LIFETRAIN)Not yet recruitingNCT07586150Not applicable
- Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes PatientsRecruitingNCT07581145Phase 3
- Tirzepatide Titration to Reduce Side Effects in Individuals With ObesityRecruitingNCT07574723Not applicable
- Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol SecretionRecruitingNCT07573163Phase 2
- Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 DiabetesRecruitingNCT07558863Phase 4
- Incretin Therapies in Obesity-related HFpEFRecruitingNCT07554638Phase 4
- Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)Enrolling by invitationNCT07547878Phase 4
- Efficacy and Safety of Triple Therapy With Dulaglutide, SGLT2 Inhibitors, and Finerenone in Chinese Adults With Type 2 Diabetes and Chronic Kidney DiseaseNot yet recruitingNCT07537088Phase 4
- A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLDRecruitingNCT07527910Phase 2
- Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscle Health)RecruitingNCT07527195Phase 1
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use DisorderRecruitingNCT07523633Phase 2
- Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke ThrombectomyNot yet recruitingNCT07511543Phase 2
- Exercise and Diabetes Interventions to Improve Brain Health in Older Adults With Type 2 DiabetesNot yet recruitingNCT07485062Phase 4
- DECODE - Haemodynamic Effects Of Semaglutide and Tirzepatide - a Series of Pilot StudiesNot yet recruitingNCT07483801Phase 4
- Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1)RecruitingNCT07481747Phase 3
- Trial of Tirzepatide for the Treatment of Cannabis Use DisorderNot yet recruitingNCT07468552Phase 2
- A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese AdultsRecruitingNCT07465965Phase 1
- A Study to Evaluate ALN-2232 in Participants With ObesityRecruitingNCT07463846Phase 1/2
- Combination of Biologic and Anti-obesity Therapies in Psoriatic ArthritisRecruitingNCT07443956Not applicable